Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.
Georgopoulos D, et al. Among authors: zakynthinos e.
Crit Care. 2005 Oct 5;9(5):R508-15. doi: 10.1186/cc3786. Epub 2005 Aug 5.
Crit Care. 2005.
PMID: 16277712
Free PMC article.
Clinical Trial.